KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
KESTRA MEDICAL TECHNOLOGIES, LTD.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$29.37+2.13 (+7.82%)
Close on Oct 19, 2026
- Market cap
- $1.72B
- P/E (TTM)
- –
- Dividend yield
- –
Kestra Medical Technologies statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Market Cap | $1.75B | $230.55M |
| Enterprise Value | $1.58B | $202.97M |
| PS Ratio | 16.39 | 3.11 |
Enterprise value
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| EV / Sales | 14.78 | 2.92 |
Income (trailing twelve months)
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Revenue | $106.73M | $102.39M |
| Gross Profit | $57.51M | $60.36M |
| Operating Income | -$143.52M | -$4.31M |
| Pretax Income | -$149.56M | -$2.26M |
| Net Income | -$149.87M | -$6.57M |
| EBITDA | -$134.18M | -$1.98M |
| EPS (Diluted) | -$2.67 | -$0.07 |
Margins
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Gross Margin | 53.9% | 55.1% |
| Operating Margin | -134.5% | -6.04% |
| Pretax Margin | -140.1% | -4.11% |
| Profit Margin | -140.4% | -10.5% |
| EBITDA Margin | -125.7% | -2.67% |
| FCF Margin | -115.0% | -0.30% |
Returns
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Return on Assets (ROA) | -48.8% | -13.3% |
| Return on Capital Employed (ROCE) | -48.0% | -9.07% |
Growth
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 60.7% | 8.85% |
Balance sheet
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $244.70M | $37.33M |
| Total Debt | $72.50M | $72.66M |
| Net Cash (Debt) | $172.21M | $3.92M |
| Net Cash Per Share | $2.89 | $0.28 |
| Working Capital | $178.00M | $54.64M |
Financial position
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Current Ratio | 4.69 | 2.50 |
| Quick Ratio | 5.39 | 1.54 |
| Interest Coverage | -18.98 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Operating Cash Flow | -$87.72M | -$653.46K |
| Capital Expenditures | -$35.06M | -$3.69M |
| Free Cash Flow | -$122.79M | -$835.02K |
| FCF Per Share | -$2.06 | -$0.02 |
Efficiency
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Asset Turnover | 0.35 | 0.59 |
| Revenue Per Employee | $240.92K | $322.57K |
| Profits Per Employee | -$338.31K | -$51.88K |
| Employee Count | 443 | 185 |
Dividends and yields
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Earnings Yield | -8.57% | -6.91% |
| FCF Yield | -7.02% | -0.56% |
Shares
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Shares Outstanding | 59,561,800 | 44,856,700 |
| Shares Change (YoY) | 72.6% | 3.35% |
| Shares Change (QoQ) | 1.52% | 0.27% |
| Float | 33,349,100 | 37,097,900 |
| Shares Held by Insiders | 44.0% | 10.6% |
Taxes
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Income Tax | $311.00K | $1.52M |
Scores
| Measure | Kestra Medical Technologies | Industry median |
|---|---|---|
| Altman Z-Score | 5.15 | 1.95 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | 1.67 | -2.64 |
Calculated by StockData from Kestra Medical Technologies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.